Merrimack Pharmaceuticals
MACK
#7637
Rank
HK$1.74 B
Marketcap
HK$117.94
Share price
0.00%
Change (1 day)
23.50%
Change (1 year)

Earnings for Merrimack Pharmaceuticals (MACK)

Earnings in 2024 (TTM): -HK$17.69 M

According to Merrimack Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -HK$17.61 M. In 2023 the company made an earning of -HK$16.97 M a decrease over its 2022 earnings that were of -HK$16.95 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Merrimack Pharmaceuticals from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$17.69 M4.23%
2023 -HK$16.97 M0.09%
2022 -HK$16.95 M-16.9%
2021 -HK$20.4 M-49.89%
2020 -HK$40.7 M-75.39%
2019 -HK$0.17 B-68.58%
2018 -HK$0.53 B-19.4%
2017 -HK$0.66 B-36.46%
2016 -HK$1.03 B2.54%
2015 -HK$1.01 B96.78%
2014 -HK$0.51 B-45.44%
2013 -HK$0.94 B
2010 -HK$0.37 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$52.61 B-298,894.16%๐Ÿ‡ซ๐Ÿ‡ท France
-HK$0.23 B 1,185.48%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.63 B 9,125.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.7 B 9,523.90%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.17 B 860.69%๐Ÿ‡บ๐Ÿ‡ธ USA